Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1395 | GSK2334470 | 0.01 | 0.8244 | 0.00149 |
| HCC1395 | GSK2334470 | 0.0316227766017 | 0.7334 | -0.00760 |
| HCC1395 | GSK2334470 | 0.0316227766017 | 1.0356 | 0.00211 |
| HCC1395 | GSK2334470 | 0.0316227766017 | 1.0478 | -0.01625 |
| HCC1395 | GSK2334470 | 0.1 | 0.9326 | -0.00130 |
| HCC1395 | GSK2334470 | 0.1 | 1.0311 | 0.09023 |
| HCC1395 | GSK2334470 | 0.1 | 0.8619 | -0.00461 |
| HCC1395 | GSK2334470 | 0.316227766017 | 0.6801 | 0.00207 |
| HCC1395 | GSK2334470 | 0.316227766017 | 0.6875 | -0.01819 |
| HCC1395 | GSK2334470 | 0.316227766017 | 0.7990 | -0.00319 |
| HCC1395 | GSK2334470 | 1.0 | 0.6417 | -0.00234 |
| HCC1395 | GSK2334470 | 1.0 | 0.7483 | -0.00701 |
| HCC1395 | GSK2334470 | 1.0 | 0.6549 | 0.00141 |
| HCC1395 | GSK2334470 | 3.16227766017 | 0.7572 | -0.00738 |
| HCC1395 | GSK2334470 | 3.16227766017 | 1.0356 | -0.03119 |
| HCC1395 | GSK2334470 | 3.16227766017 | 0.7871 | 0.02785 |
| HCC1395 | GSK2334470 | 10.0 | 0.4704 | 0.01440 |
| HCC1395 | GSK2334470 | 10.0 | 0.6019 | -0.00047 |
| HCC1395 | GSK2334470 | 10.0 | 0.4791 | 0.05139 |
| HCC1395 | Ribociclib | 0.001 | 0.9191 | -0.00794 |
| HCC1395 | Ribociclib | 0.001 | 0.7127 | -0.01042 |
| HCC1395 | Ribociclib | 0.001 | 0.8739 | 0.00607 |
| HCC1395 | Ribociclib | 0.00316227766017 | 0.8184 | 0.03156 |
| HCC1395 | Ribociclib | 0.00316227766017 | 0.6845 | 0.01152 |
| HCC1395 | Ribociclib | 0.00316227766017 | 0.9795 | 0.01631 |